Health Law & Business News

Novartis to Pay $678m to Settle Fraud Lawsuit, U.S. DOJ says

July 1, 2020, 10:28 PM

Novartis Pharmaceuticals agreed to pay $678m to the U.S. and various states to settle a fraud lawsuit, the U.S. Justice Department said.

  • The suit alleged Novartis operated a sham speaker series and provided doctors cash, outings, meals and alcohol to induce them to prescribe Novartis cardiovascular and diabetes drugs reimbursed by federal healthcare programs

To view the source of this information click here

To contact the reporter on this story:
Greg Chang in San Francisco at gchang1@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

To read the full article log in. To learn more about a subscription click here.